NCT03100552 (SERRESH) is a clinical trial of Endoscopic imaging in Sessile Serrated Adenoma, sponsored by Western Sydney Local Health District.

Who is sponsoring NCT03100552?

NCT03100552 is sponsored by Western Sydney Local Health District.

What drugs are being tested in NCT03100552?

Interventions in NCT03100552: Endoscopic imaging.

What condition does NCT03100552 study?

NCT03100552 studies Sessile Serrated Adenoma.

Is NCT03100552 still recruiting?

NCT03100552 is currently completed. Last updated 29 June 2023.

Last reviewed 2023-06-29 · How we verify

NCT03100552: SERRESH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prediction of Dysplasia Within Sessile Serrated Polyps Using Endoscopic Imaging; a Prospective Observational Study

Completed Last updated 29 June 2023

What this trial tests

trial testing Endoscopic imaging in Sessile Serrated Adenoma in 86 participants. Completed in 1 January 2017.

Timeline

1 August 2013

Primary endpoint
1 January 2017

1 January 2017

Quick facts

Lead sponsor	Western Sydney Local Health District
Status	Completed
Study type	OBSERVATIONAL
Enrollment	86
Start date	1 August 2013
Primary completion	1 January 2017
Estimated completion	1 January 2017
Sites	1 location across Australia

Drugs / interventions tested

Endoscopic imaging

Conditions studied

Sessile Serrated Adenoma — all drugs for Sessile Serrated Adenoma →

Sponsor

Western Sydney Local Health District — full company profile →

Who can join

Eligibility, any sex, with Sessile Serrated Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study of endoscopic imaging in the detection of dysplasia within serrated colonic lesions \>= 8mm in size

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sessile Serrated Adenoma

Currently open trials in the same condition.

NCT03089268 — Molecular and Histological Characteristics of Serrated Lesions of the Colon · active not recruiting

Other Western Sydney Local Health District trials

Trials by the same sponsor.

NCT07445334 — Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes · NA · not yet recruiting
NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
NCT06365411 — GEnomic Medicine in Kidney Transplantation Study · not yet recruiting
NCT06828562 — GENomic Predictors in A Multi-Ethnic Population With Kidney Disease Study · enrolling by invitation
NCT05509153 — A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03100552 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Western Sydney Local Health District
Last refreshed: 29 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03100552.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing